Sybron Dental Specialties, Inc. Acquires Oraltronics Dental Implant Technology GmbH
08 Junho 2005 - 8:40PM
PR Newswire (US)
Sybron Dental Specialties, Inc. Acquires Oraltronics Dental Implant
Technology GmbH ORANGE, Calif., June 8 /PRNewswire-FirstCall/ --
Sybron Dental Specialties, Inc. (NYSE:SYD), a leading manufacturer
of a broad range of value-added products for the dental profession
including the specialty markets of endodontics, implantology, and
orthodontics, announced today that its subsidiary Ormco B.V.
acquired all of the outstanding stock of Oraltronics Dental Implant
Technology GmbH ("Oraltronics"), a privately held company
headquartered in Bremen, Germany engaged in the manufacture and
sale of dental implants. Established in 1979, by Professor Hans L.
Grafelmann, Oraltronics generated annual revenues of approximately
$10 million in 2004. The purchase of the company was made using
Sybron Dental Specialties' existing cash. The Company expects the
acquisition to be accretive within the first year of operations.
(Logo: http://www.newscom.com/cgi-bin/prnh/20001204/SDSLOGO)
"Oraltronics represents an ideal addition to our subsidiary Innova
Lifesciences, which we acquired last October as a means of entering
the rapidly growing dental implant market," said Floyd W. Pickrell,
Jr., Chief Executive Officer of Sybron Dental Specialties.
"Oraltronics not only increases our scale in this exciting segment
of dentistry, it also provides a strong presence in several key
countries in Europe that will serve as an excellent platform to
promote the sale of Innova's press fit implant design in Europe. In
addition, we believe the addition of Oraltronics' patented implant
design will have a positive impact on Innova's sales in the United
States and Canada." Oraltronics will be managed by the Company's
Innova subsidiary, which continues to be led by Innova's founder
and President, Mr. Michael Kehoe. "We are very pleased to add the
highly regarded Oraltronics implants to the Innova product line,"
said Mr. Kehoe. "Their threaded implant design offers an excellent
complement to our Endopore product and we look forward to the
opportunities that this acquisition offers to drive the worldwide
sales of both the Oraltronics and Innova brands via a strengthened
sales and distribution network." CAUTION REGARDING FORWARD-LOOKING
STATEMENTS Statements made in this press release regarding future
matters are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements, including those dealing with the Company's expectations
as to its future revenue, earnings per share, the demand for its
products, the benefits of the Oraltronics acquisition, and the
ability of the Innova sales force to sell Oraltronics' products are
based on the Company's current expectations. Our actual results may
differ materially from those currently expected or desired because
of a number of risks and uncertainties, including the level of
demand for the Company's products; the ability to obtain regulatory
approval to sell the Oraltronics products in the United States and
Canada; currency fluctuations; the intensity of competition; and
other factors affecting the Company's business and prospects
discussed in the filings made by the Company, from time to time,
with the SEC including the factors discussed in the "Cautionary
Factors" section in Item 7 of the Company's most recent Annual
Report on Form 10-K and its periodic reports on Form 10-Q and 8-K
(if any). We undertake no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events or otherwise.
http://www.newscom.com/cgi-bin/prnh/20001204/SDSLOGO
http://photoarchive.ap.org/ DATASOURCE: Sybron Dental Specialties,
Inc. CONTACT: Bernard J. Pitz, Chief Financial Officer of Sybron
Dental Specialties, Inc., +1-714-516-7910
Copyright
Sybron Dental (NYSE:SYD)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Sybron Dental (NYSE:SYD)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Sybron Dental Specialties da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Sybron Dental